1 year return (CAGR)
-81.61%
Mereo BioPharma Group PLC ADR Exchange (NASDAQ, USD)
MREO
0.34
+0.02 (+7.69%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-38.46%
5 year return (CAGR)
-33.26%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
54.34M
Price/Sales
-
Ent value
30.29M
Price/Book
1.90
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-35.75%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.32 |
| Daily high | 0.37 |
| Daily low | 0.31 |
| Daily Volume | 3.90M |
| All-time high | 5.92 |
| 1y analyst estimate | 1.99 |
| Beta | 0.30 |
| EPS (TTM) | -0.17 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 1 Apr 2026 |
Downside potential
Loading...
Downside potential data
| MREO | S&P500 | |
| Current price drop from All-time high | -94.25% | -1.29% |
| Highest price drop | -96.00% | -56.47% |
| Date of highest drop | 18 May 2026 | 9 Mar 2009 |
| Avg drop from high | -63.86% | -10.68% |
| Avg time to new high | 932 days | 12 days |
| Max time to new high | 1864 days | 1805 days |
News
